glucose Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
845 492-61-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • dextrose
  • D-Glucose
  • (+)-Glucose
  • glucose
  • dextrose monohydrate
  • anhydrous dextrose
  • glucose monohydrate
  • anhydrous glucose
A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.
  • Molecular weight: 180.16
  • Formula: C6H12O6
  • CLOGP: -2.90
  • LIPINSKI: 0
  • HAC: 6
  • HDO: 5
  • TPSA: 110.38
  • ALOGS: 0.16
  • ROTB: 5

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

PropertyValueReference
BA (Bioavailability) 99 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H

Approvals:

DateAgencyCompanyOrphan
Jan. 17, 1946 FDA B BRAUN

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Peritonitis bacterial 1928.01 9.65 761 123171 7892 46554238
Death 1806.18 9.65 3201 120731 332347 46229783
Peritonitis 1436.94 9.65 814 123118 19900 46542230
Fluid overload 872.11 9.65 659 123273 26526 46535604
Peritoneal dialysis complication 809.79 9.65 295 123637 2399 46559731
Drug ineffective 460.82 9.65 682 123250 677156 45884974
Rheumatoid arthritis 380.60 9.65 86 123846 240129 46322001
Bloody peritoneal effluent 265.47 9.65 83 123849 394 46561736
Sepsis 243.24 9.65 854 123078 135160 46426970
Ultrafiltration failure 224.14 9.65 78 123854 546 46561584
Cardiac failure congestive 223.48 9.65 641 123291 91109 46471021
Hypokalaemia 196.26 9.65 596 123336 87428 46474702
Fungal peritonitis 189.80 9.65 75 123857 778 46561352
Dehydration 170.63 9.65 856 123076 158684 46403446
Hypotension 161.86 9.65 1114 122818 231475 46330655
Pneumonia 147.96 9.65 1587 122345 374733 46187397
Off label use 142.95 9.65 523 123409 379318 46182812
Arthralgia 141.86 9.65 495 123437 364108 46198022
Joint swelling 131.66 9.65 148 123784 165925 46396205
Blood potassium decreased 125.50 9.65 298 123634 37765 46524365
Cardiac arrest 123.19 9.65 521 123411 89878 46472252
Abdominal distension 116.12 9.65 443 123489 72908 46489222
Acute myocardial infarction 115.22 9.65 259 123673 31665 46530465
Contraindicated product administered 107.28 9.65 39 123893 79908 46482222
Drug abuse 105.81 9.65 20 123912 63388 46498742
Colitis microscopic 104.77 9.65 107 123825 6449 46555681
Catheter site infection 103.42 9.65 92 123840 4661 46557469
Alopecia 101.36 9.65 172 123760 162242 46399888
Drug hypersensitivity 100.87 9.65 322 123610 243503 46318627
Hypervolaemia 99.06 9.65 60 123872 1662 46560468
Hyperkalaemia 98.89 9.65 328 123604 50381 46511749
Diabetic foot 98.82 9.65 59 123873 1591 46560539
Fluid retention 98.49 9.65 329 123603 50717 46511413
Bone marrow failure 92.14 9.65 227 123705 29442 46532688
Respiratory failure 90.37 9.65 493 123439 94323 46467807
Peritoneal cloudy effluent 89.37 9.65 32 123900 246 46561884
Pain 88.97 9.65 824 123108 476124 46086006
Therapeutic product effect decreased 84.24 9.65 58 123874 82543 46479587
Procedural pain 83.68 9.65 136 123796 13043 46549087
Pleural effusion 83.59 9.65 438 123494 82514 46479616
Completed suicide 83.47 9.65 163 123769 145757 46416373
Psoriasis 83.13 9.65 53 123879 78551 46483579
Pulmonary oedema 81.14 9.65 309 123623 50796 46511334
Injection site pain 81.10 9.65 99 123833 107053 46455077
Disease complication 81.07 9.65 66 123866 2959 46559171
Therapeutic product effect incomplete 79.54 9.65 55 123877 78098 46484032
Cardiovascular disorder 79.06 9.65 127 123805 12060 46550070
Toxicity to various agents 78.53 9.65 293 123639 211473 46350657
Cardio-respiratory arrest 77.63 9.65 340 123592 59529 46502601
Multimorbidity 77.63 9.65 38 123894 680 46561450
Hand deformity 75.28 9.65 4 123928 34570 46527560
Hypoxia 74.68 9.65 304 123628 51534 46510596
Abortion spontaneous 74.47 9.65 13 123919 43633 46518497
Cerebrovascular accident 73.70 9.65 490 123442 100549 46461581
Musculoskeletal stiffness 73.67 9.65 91 123841 97902 46464228
Pneumonia aspiration 72.24 9.65 216 123716 31389 46530741
Arthropathy 72.10 9.65 71 123861 84629 46477501
Gastrointestinal haemorrhage 71.50 9.65 399 123533 76974 46485156
Malnutrition 71.22 9.65 131 123801 13872 46548258
Myocardial infarction 69.94 9.65 471 123461 97057 46465073
Headache 68.48 9.65 878 123054 477474 46084656
Atrial fibrillation 67.08 9.65 488 123444 103102 46459028
Pulmonary hypertension 66.79 9.65 229 123703 35764 46526366
Oedema peripheral 65.50 9.65 680 123252 159026 46403104
Product use issue 64.93 9.65 94 123838 94550 46467580
Systemic lupus erythematosus 64.84 9.65 47 123885 65133 46496997
Rash 64.18 9.65 621 123311 355891 46206239
Infusion related reaction 61.44 9.65 109 123823 101099 46461031
Inadequate aseptic technique in use of product 61.39 9.65 20 123912 111 46562019
Acute respiratory failure 60.88 9.65 193 123739 28945 46533185
Drug intolerance 60.87 9.65 194 123738 146855 46415275
Right ventricular failure 60.80 9.65 133 123799 15960 46546170
Cardiac disorder 59.87 9.65 253 123679 43605 46518525
Cardiac failure 59.67 9.65 390 123542 79558 46482572
Suicidal ideation 59.63 9.65 38 123894 56344 46505786
Maternal exposure during pregnancy 59.10 9.65 114 123818 102435 46459695
Injection site erythema 53.97 9.65 71 123861 74356 46487774
Fluid imbalance 53.20 9.65 25 123907 407 46561723
Glaucoma 52.84 9.65 125 123807 15796 46546334
Glossodynia 52.54 9.65 26 123906 44347 46517783
Injection site reaction 52.34 9.65 31 123901 47818 46514312
Hypoglycaemia 51.35 9.65 282 123650 54067 46508063
Pleuroperitoneal communication 49.26 9.65 15 123917 64 46562066
Abdominal pain 49.24 9.65 871 123061 229160 46332970
Asthenia 48.70 9.65 1124 122808 309951 46252179
Lower respiratory tract infection 48.24 9.65 45 123887 55044 46507086
Non-cardiogenic pulmonary oedema 46.88 9.65 25 123907 539 46561591
Asthma 46.69 9.65 109 123823 91433 46470697
Electrolyte imbalance 46.45 9.65 125 123807 17101 46545029
Intentional self-injury 46.41 9.65 5 123927 24161 46537969
Device related infection 46.38 9.65 142 123790 20899 46541231
Oedema 46.33 9.65 321 123611 66750 46495380
Mental status changes 46.12 9.65 212 123720 37876 46524254
Renal ischaemia 45.31 9.65 25 123907 578 46561552
Injection site bruising 45.12 9.65 19 123913 35617 46526513
Injection site swelling 44.28 9.65 26 123906 40301 46521829
Nasopharyngitis 43.82 9.65 235 123697 153763 46408367
Psoriatic arthropathy 42.05 9.65 22 123910 36357 46525773
Exposure during pregnancy 41.86 9.65 147 123785 108065 46454065
Myelosuppression 41.64 9.65 74 123858 7629 46554501
Drug interaction 41.17 9.65 343 123589 202751 46359379
Sopor 41.05 9.65 3 123929 19825 46542305
Diverticulitis 40.82 9.65 185 123747 32854 46529276
Urticaria 39.91 9.65 169 123763 117723 46444407
Fatigue 39.02 9.65 1276 122656 607421 45954709
Diabetic complication 38.85 9.65 27 123905 950 46561180
Pregnancy 38.55 9.65 12 123920 27125 46535005
Injection site pruritus 37.80 9.65 30 123902 39713 46522417
Dyspnoea 37.47 9.65 1699 122233 513849 46048281
Septic shock 37.03 9.65 272 123660 57621 46504509
Treatment failure 36.98 9.65 125 123807 92962 46469168
Noninfectious peritonitis 36.80 9.65 16 123916 215 46561915
Cytokine release syndrome 36.53 9.65 62 123870 6161 46555969
Hernia 36.48 9.65 80 123852 9615 46552515
PO2 increased 36.34 9.65 25 123907 865 46561265
Arthritis 35.59 9.65 97 123835 77219 46484911
Loss of personal independence in daily activities 35.22 9.65 61 123871 57122 46505008
C-reactive protein abnormal 34.86 9.65 7 123925 21263 46540867
Hypophagia 34.65 9.65 162 123770 29144 46532986
Diabetes insipidus 33.86 9.65 35 123897 2139 46559991
Peritoneal effluent abnormal 33.48 9.65 11 123921 63 46562067
Gangrene 33.33 9.65 51 123881 4644 46557486
Catheter site extravasation 33.32 9.65 15 123917 220 46561910
Blood urea increased 32.86 9.65 144 123788 25208 46536922
Hypersensitivity 32.70 9.65 249 123683 150072 46412058
Product use in unapproved indication 32.69 9.65 126 123806 90147 46471983
Drug reaction with eosinophilia and systemic symptoms 32.51 9.65 19 123913 29529 46532601
Haemoglobin decreased 31.86 9.65 500 123432 128449 46433681
Failure to thrive 30.98 9.65 60 123872 6604 46555526
PCO2 increased 30.77 9.65 26 123906 1228 46560902
Umbilical hernia 30.64 9.65 37 123895 2687 46559443
Therapeutic response decreased 30.42 9.65 42 123890 43103 46519027
Pulmonary arterial hypertension 30.42 9.65 143 123789 25785 46536345
Anaemia 29.75 9.65 889 123043 254890 46307240
Paraesthesia 29.24 9.65 187 123745 117250 46444880
Azotaemia 29.13 9.65 46 123886 4305 46557825
Blood magnesium decreased 28.87 9.65 79 123853 10913 46551217
Cardiac dysfunction 28.80 9.65 27 123905 1464 46560666
Renal failure 28.26 9.65 441 123491 113153 46448977
International normalised ratio increased 28.13 9.65 217 123715 46666 46515464
Cor pulmonale 27.98 9.65 30 123902 1913 46560217
Multiple sclerosis relapse 27.75 9.65 43 123889 42082 46520048
Blood bilirubin increased 27.49 9.65 170 123762 34014 46528116
Treatment noncompliance 27.23 9.65 153 123779 29578 46532552
Device occlusion 26.99 9.65 53 123879 5892 46556238
Acute kidney injury 26.95 9.65 818 123114 235037 46327093
Brain natriuretic peptide increased 25.56 9.65 45 123887 4605 46557525
Pneumoperitoneum 25.45 9.65 25 123907 1437 46560693
Febrile neutropenia 25.33 9.65 372 123560 94255 46467875
Atrial flutter 25.29 9.65 67 123865 9081 46553049
Gastrooesophageal reflux disease 25.17 9.65 305 123627 74039 46488091
Overdose 25.07 9.65 163 123769 101816 46460314
Hepatocellular injury 24.82 9.65 25 123907 29497 46532633
Serotonin syndrome 24.69 9.65 17 123915 24203 46537927
Migraine 24.55 9.65 99 123833 69927 46492203
Hypernatraemia 24.29 9.65 53 123879 6348 46555782
Insomnia 24.11 9.65 301 123631 164623 46397507
Inappropriate schedule of product administration 24.01 9.65 90 123842 64923 46497207
Chronic obstructive pulmonary disease 23.86 9.65 246 123686 57387 46504743
Blood glucose decreased 23.50 9.65 106 123826 18786 46543344
Inflammation 23.36 9.65 60 123872 48721 46513409
Blood pressure decreased 23.21 9.65 243 123689 56916 46505214
Herpes zoster 23.14 9.65 97 123835 67775 46494355
Heparin-induced thrombocytopenia 22.78 9.65 41 123891 4268 46557862
Blood calcium decreased 22.62 9.65 92 123840 15581 46546549
Blood albumin decreased 22.54 9.65 84 123848 13661 46548469
Acute left ventricular failure 22.15 9.65 18 123914 805 46561325
Sinusitis 22.03 9.65 229 123703 129539 46432591
Hyperglycaemia 21.98 9.65 164 123768 34907 46527223
Metabolic alkalosis 21.92 9.65 31 123901 2629 46559501
Wrong product administered 21.80 9.65 47 123885 5583 46556547
Intentional product misuse 21.78 9.65 59 123873 47069 46515061
Pericarditis 21.59 9.65 19 123913 23908 46538222
Abdominal hernia 21.41 9.65 42 123890 4666 46557464
Extremity necrosis 21.41 9.65 24 123908 1609 46560521
Vertigo 21.28 9.65 69 123863 51979 46510151
Cardiogenic shock 21.18 9.65 93 123839 16291 46545839
Posterior reversible encephalopathy syndrome 20.96 9.65 7 123925 15134 46546996
Red blood cell sedimentation rate increased 20.87 9.65 18 123914 22871 46539259
Encapsulating peritoneal sclerosis 20.87 9.65 13 123919 379 46561751
Urine chloride decreased 20.68 9.65 8 123924 78 46562052
Wrong technique in product usage process 20.32 9.65 75 123857 54347 46507783
Wound 20.22 9.65 53 123879 42749 46519381
Blood potassium increased 20.21 9.65 94 123838 16873 46545257
Hypovolaemia 20.20 9.65 65 123867 9823 46552307
Condition aggravated 20.10 9.65 496 123436 244556 46317574
Depression 20.07 9.65 324 123608 169780 46392350
Peritoneal effluent leukocyte count increased 20.01 9.65 6 123926 24 46562106
Blood bicarbonate decreased 20.00 9.65 31 123901 2854 46559276
Decreased appetite 19.95 9.65 664 123268 193172 46368958
Deep vein thrombosis 19.94 9.65 310 123622 79463 46482667
Injection site warmth 19.72 9.65 6 123926 13766 46548364
Joint stiffness 19.50 9.65 26 123906 27082 46535048
Encephalopathy 19.34 9.65 154 123778 33435 46528695
Blood pH decreased 19.31 9.65 29 123903 2598 46559532
Electrocardiogram T wave peaked 19.29 9.65 10 123922 203 46561927
Hepatitis 19.26 9.65 35 123897 32180 46529950
Sleep disorder 19.15 9.65 62 123870 46733 46515397
Osteoarthritis 19.12 9.65 92 123840 61933 46500197
Acne 18.98 9.65 15 123917 19904 46542226
Bacterial translocation 18.78 9.65 10 123922 215 46561915
Pain in extremity 18.74 9.65 533 123399 258147 46303983
Bacteraemia 18.73 9.65 81 123851 14098 46548032
Suicide attempt 18.54 9.65 79 123853 54957 46507173
Oropharyngeal pain 18.50 9.65 118 123814 74050 46488080
Pruritus 18.42 9.65 496 123436 241856 46320274
Osteonecrosis of jaw 18.31 9.65 40 123892 34362 46527768
Intentional product use issue 18.26 9.65 75 123857 52705 46509425
Cardiac failure acute 18.25 9.65 55 123877 8023 46554107
Respiratory distress 18.19 9.65 146 123786 31770 46530360
Cardiomegaly 18.06 9.65 93 123839 17389 46544741
Plasma cell myeloma 18.01 9.65 189 123743 44289 46517841
Transfusion 17.79 9.65 76 123856 13155 46548975
Prothrombin time prolonged 17.75 9.65 61 123871 9535 46552595
Pulse absent 17.64 9.65 40 123892 4916 46557214
Hypomagnesaemia 17.57 9.65 110 123822 22100 46540030
Hydrothorax 17.56 9.65 14 123918 609 46561521
Hepatic enzyme increased 17.52 9.65 136 123796 81651 46480479
Oxygen saturation abnormal 17.19 9.65 28 123904 2690 46559440
Peritoneal disorder 17.18 9.65 13 123919 523 46561607
Product storage error 17.13 9.65 5 123927 11787 46550343
Oxygen consumption increased 17.05 9.65 33 123899 3630 46558500
Tonsillar haemorrhage 16.96 9.65 9 123923 192 46561938
Oral herpes 16.78 9.65 16 123916 19374 46542756
Knee arthroplasty 16.72 9.65 23 123909 23642 46538488
Gait disturbance 16.69 9.65 278 123654 144985 46417145
Procedural complication 16.68 9.65 39 123893 4891 46557239
Critical illness 16.55 9.65 8 123924 139 46561991
Vomiting 16.42 9.65 1405 122527 451389 46110741
Metabolic encephalopathy 16.41 9.65 41 123891 5362 46556768
Mental status changes postoperative 16.39 9.65 9 123923 206 46561924
Urinary tract infection 16.36 9.65 728 123204 219538 46342592
Staphylococcus test positive 16.33 9.65 32 123900 3552 46558578
Injection site rash 16.25 9.65 11 123921 15802 46546328
Marasmus 16.21 9.65 12 123920 467 46561663
Abdominal pain upper 16.08 9.65 280 123652 145025 46417105
Cognitive disorder 15.70 9.65 48 123884 36835 46525295
Hip arthroplasty 15.61 9.65 15 123917 18097 46544033
Foot deformity 15.49 9.65 11 123921 15414 46546716
Coma 15.45 9.65 229 123703 58120 46504010
Accidental exposure to product 15.39 9.65 20 123912 21061 46541069
Urine sodium decreased 15.36 9.65 8 123924 164 46561966
Extravasation 15.05 9.65 23 123909 2092 46560038
Arrhythmia 15.04 9.65 150 123782 34691 46527439
Hypoaesthesia 14.83 9.65 224 123708 118645 46443485
Acinetobacter sepsis 14.80 9.65 3 123929 0 46562130
Product quality issue 14.75 9.65 47 123885 35601 46526529
Dry eye 14.74 9.65 37 123895 30285 46531845
Product substitution issue 14.73 9.65 11 123921 15020 46547110
Oxalosis 14.62 9.65 5 123927 33 46562097
Erythema 14.61 9.65 279 123653 142541 46419589
Tendonitis 14.58 9.65 10 123922 14267 46547863
Device related sepsis 14.56 9.65 29 123903 3258 46558872
Anxiety 14.45 9.65 370 123562 181587 46380543
Bronchitis 14.43 9.65 376 123556 105603 46456527
Vascular device infection 14.36 9.65 30 123902 3487 46558643
Hot flush 14.33 9.65 63 123869 43454 46518676
Atelectasis 14.21 9.65 92 123840 18698 46543432
Decubitus ulcer 14.21 9.65 58 123874 9840 46552290
Unresponsive to stimuli 14.12 9.65 139 123793 32035 46530095
Multiple organ dysfunction syndrome 14.11 9.65 204 123728 51506 46510624
Poisoning 14.03 9.65 10 123922 13984 46548146
Catheter management 14.02 9.65 26 123906 2769 46559361
Interstitial lung disease 13.88 9.65 85 123847 53864 46508266
Abortion induced 13.76 9.65 5 123927 10255 46551875
Haematocrit decreased 13.74 9.65 148 123784 34909 46527221
Blood glucose increased 13.73 9.65 268 123664 71745 46490385
Skin dystrophy 13.58 9.65 5 123927 42 46562088
Nosocomial infection 13.40 9.65 19 123913 1616 46560514
Myalgia 13.35 9.65 238 123694 122850 46439280
Postoperative adhesion 13.29 9.65 8 123924 219 46561911
Calciphylaxis 13.25 9.65 24 123908 2511 46559619
Catheter site abscess 13.18 9.65 5 123927 46 46562084
Confusion postoperative 13.16 9.65 8 123924 223 46561907
Blood cholesterol increased 13.13 9.65 58 123874 39955 46522175
Alkalosis 13.12 9.65 9 123923 310 46561820
Depressed mood 13.05 9.65 45 123887 33274 46528856
Intentional overdose 12.99 9.65 110 123822 64834 46497296
Labelled drug-drug interaction medication error 12.88 9.65 4 123928 9057 46553073
Full blood count decreased 12.87 9.65 102 123830 22109 46540021
Posthaemorrhagic hydrocephalus 12.79 9.65 4 123928 19 46562111
Small intestinal obstruction 12.73 9.65 80 123852 16092 46546038
Hypoalbuminaemia 12.73 9.65 57 123875 10070 46552060
Impaired work ability 12.71 9.65 9 123923 12627 46549503
Blood potassium abnormal 12.64 9.65 21 123911 2051 46560079
Supraventricular tachycardia 12.62 9.65 69 123863 13201 46548929
Thrombocytopenia 12.60 9.65 432 123500 126149 46435981
Pharyngitis 12.51 9.65 17 123915 17566 46544564
Fibromyalgia 12.49 9.65 52 123880 36411 46525719
Ventricular fibrillation 12.47 9.65 62 123870 11434 46550696
Generalised oedema 12.46 9.65 73 123859 14326 46547804
Psychomotor hyperactivity 12.37 9.65 5 123927 9608 46552522
Thyroid disorder 12.31 9.65 64 123868 12012 46550118
Tissue injury 12.31 9.65 4 123928 22 46562108
Movement disorder 12.28 9.65 16 123916 16833 46545297
Helicobacter infection 12.28 9.65 8 123924 11728 46550402
Nodule 12.24 9.65 14 123918 15591 46546539
Poisoning deliberate 12.20 9.65 3 123929 7923 46554207
Ventricular tachycardia 12.18 9.65 82 123850 16885 46545245
Product selection error 12.16 9.65 5 123927 58 46562072
Haemorrhage 12.14 9.65 209 123723 54660 46507470
Activated partial thromboplastin time prolonged 12.05 9.65 43 123889 6846 46555284
Injection site haemorrhage 11.94 9.65 23 123909 20686 46541444
Grip strength decreased 11.88 9.65 4 123928 8602 46553528
Calcium deficiency 11.74 9.65 13 123919 860 46561270
Akathisia 11.72 9.65 3 123929 7711 46554419
Cyst 11.67 9.65 9 123923 12091 46550039
Chest pain 11.63 9.65 576 123356 175748 46386382
Incarcerated hernia 11.61 9.65 6 123926 121 46562009
Sudden death 11.57 9.65 53 123879 9451 46552679
Cytotoxic oedema 11.57 9.65 6 123926 122 46562008
Nutritional condition abnormal 11.52 9.65 12 123920 740 46561390
Gastrointestinal stoma output decreased 11.49 9.65 4 123928 28 46562102
Ascites 11.48 9.65 148 123784 36436 46525694
Chronic kidney disease 11.45 9.65 162 123770 40709 46521421
Stress 11.38 9.65 85 123847 51466 46510664
Product residue present 11.31 9.65 29 123903 3853 46558277
Clostridium difficile infection 11.28 9.65 109 123823 24994 46537136
Tenosynovitis 11.27 9.65 3 123929 7512 46554618
Infantile apnoea 11.21 9.65 12 123920 764 46561366
Incision site pain 11.20 9.65 14 123918 1053 46561077
Drug resistance 11.18 9.65 18 123914 17350 46544780
Oncologic complication 11.10 9.65 6 123926 133 46561997
Neuroleptic malignant syndrome 11.08 9.65 8 123924 11114 46551016
Breast cancer 11.05 9.65 73 123859 45445 46516685
Shock 10.90 9.65 97 123835 21748 46540382
Product compounding quality issue 10.86 9.65 6 123926 139 46561991
Influenza like illness 10.85 9.65 99 123833 57471 46504659
Retinal ischaemia 10.84 9.65 8 123924 310 46561820
Cardiac procedure complication 10.83 9.65 7 123925 218 46561912
Disturbance in attention 10.82 9.65 45 123887 31515 46530615
Torsade de pointes 10.77 9.65 62 123870 12092 46550038
Sinoatrial block 10.69 9.65 12 123920 806 46561324
Gallbladder necrosis 10.67 9.65 3 123929 9 46562121
Mania 10.55 9.65 8 123924 10838 46551292
Hyperchloraemia 10.51 9.65 11 123921 682 46561448
Colitis 10.45 9.65 148 123784 37199 46524931
Corynebacterium test positive 10.43 9.65 4 123928 38 46562092
Infusion site necrosis 10.43 9.65 4 123928 38 46562092
Muscle spasticity 10.43 9.65 9 123923 11431 46550699
Hyperdynamic left ventricle 10.38 9.65 6 123926 152 46561978
Central nervous system injury 10.38 9.65 6 123926 152 46561978
Vascular access malfunction 10.34 9.65 4 123928 39 46562091
Hepatotoxicity 10.33 9.65 33 123899 24976 46537154
Blood pressure increased 10.20 9.65 257 123675 126409 46435721
Granulocytopenia 10.17 9.65 34 123898 5239 46556891
Schizophrenia 10.17 9.65 5 123927 8563 46553567
Cardiovascular insufficiency 10.14 9.65 15 123917 1326 46560804
Extrapyramidal disorder 10.10 9.65 9 123923 11259 46550871
Clostridium difficile colitis 10.10 9.65 84 123848 18469 46543661
Urine output decreased 10.09 9.65 57 123875 11040 46551090
Abdominal discomfort 10.05 9.65 315 123617 150850 46411280
Pseudomonas peritonitis 10.01 9.65 3 123929 12 46562118
Electrocardiogram U wave present 9.99 9.65 5 123927 94 46562036
Mobility decreased 9.84 9.65 108 123824 60486 46501644
Device leakage 9.83 9.65 34 123898 5331 46556799
Diabetic vascular disorder 9.76 9.65 4 123928 46 46562084
Cellulitis 9.75 9.65 250 123682 70038 46492092
Chronic respiratory failure 9.74 9.65 17 123915 1727 46560403
Cytomegalovirus infection 9.74 9.65 21 123911 18123 46544007
Blood chloride decreased 9.71 9.65 34 123898 5363 46556767
Staphylococcal infection 9.71 9.65 141 123791 35630 46526500
Drug ineffective for unapproved indication 9.66 9.65 18 123914 16395 46545735

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Peritonitis bacterial 2473.36 10.06 1020 89878 10358 29851222
Peritonitis 1910.17 10.06 1038 89860 20337 29841243
Death 1899.25 10.06 3648 87250 353635 29507945
Peritoneal dialysis complication 1175.29 10.06 450 90448 3677 29857903
Fluid overload 1067.08 10.06 685 90213 18407 29843173
Abdominal distension 317.32 10.06 528 90370 45181 29816399
Ultrafiltration failure 310.20 10.06 108 90790 649 29860931
Drug ineffective 254.76 10.06 401 90497 339986 29521594
Fungal peritonitis 254.68 10.06 109 90789 1217 29860363
Bloody peritoneal effluent 232.58 10.06 80 90818 461 29861119
Sepsis 213.90 10.06 945 89953 145450 29716130
Drug abuse 195.07 10.06 14 90884 82058 29779522
Procedural pain 188.08 10.06 142 90756 4967 29856613
Catheter site infection 163.63 10.06 99 90799 2382 29859198
Hypotension 162.18 10.06 1102 89796 199463 29662117
Cardiac failure congestive 154.86 10.06 585 90313 83822 29777758
Peritoneal cloudy effluent 140.13 10.06 52 90846 385 29861195
Cardiac disorder 139.74 10.06 347 90551 39546 29822034
Off label use 137.66 10.06 350 90548 248940 29612640
Hypokalaemia 132.14 10.06 393 90505 49799 29811781
Cardiac arrest 132.05 10.06 595 90303 92255 29769325
Diabetic foot 127.82 10.06 88 90810 2657 29858923
Fluid retention 127.77 10.06 253 90645 24745 29836835
Cardiac failure 120.43 10.06 537 90361 82881 29778699
Drug interaction 115.72 10.06 273 90625 199295 29662285
Toxicity to various agents 113.76 10.06 229 90669 176954 29684626
Multimorbidity 105.77 10.06 44 90854 455 29861125
Dehydration 105.75 10.06 689 90209 122850 29738730
Inadequate aseptic technique in use of product 105.13 10.06 33 90865 135 29861445
Device related infection 102.82 10.06 185 90713 16830 29844750
Hypervolaemia 90.19 10.06 62 90836 1867 29859713
Hernia 89.81 10.06 121 90777 8565 29853015
Rheumatoid arthritis 82.67 10.06 13 90885 41184 29820396
Fluid imbalance 81.53 10.06 34 90864 354 29861226
Inguinal hernia 80.66 10.06 104 90794 7051 29854529
Cardiovascular disorder 80.59 10.06 130 90768 10822 29850758
Disease complication 80.00 10.06 65 90833 2534 29859046
Acute myocardial infarction 72.74 10.06 336 90562 52603 29808977
Cardio-respiratory arrest 70.99 10.06 353 90545 56953 29804627
Headache 66.96 10.06 305 90593 182001 29679579
Diabetic complication 66.60 10.06 39 90859 882 29860698
Suicide attempt 64.37 10.06 16 90882 36681 29824899
Arthralgia 63.49 10.06 206 90692 135585 29725995
Psoriasis 61.41 10.06 26 90872 42480 29819100
Peritoneal disorder 60.30 10.06 28 90870 384 29861196
Noninfectious peritonitis 59.39 10.06 23 90875 194 29861386
Myocardial infarction 57.78 10.06 609 90289 125016 29736564
Pneumonia 56.46 10.06 1369 89529 332937 29528643
Blood potassium decreased 56.27 10.06 143 90755 16519 29845061
Device occlusion 55.42 10.06 80 90818 6040 29855540
Peritoneal effluent abnormal 55.10 10.06 20 90878 138 29861442
Overdose 51.49 10.06 112 90786 84225 29777355
Pulmonary oedema 51.02 10.06 266 90632 43709 29817871
Treatment failure 50.43 10.06 21 90877 34658 29826922
Injection site pain 49.81 10.06 15 90883 30295 29831285
Azotaemia 49.70 10.06 68 90830 4884 29856696
Product use in unapproved indication 47.40 10.06 95 90803 73598 29787982
Heparin-induced thrombocytopenia 46.76 10.06 69 90829 5314 29856266
Umbilical hernia 44.09 10.06 55 90843 3606 29857974
Therapeutic product effect incomplete 42.39 10.06 25 90873 33809 29827771
Incision site pain 41.43 10.06 40 90858 1964 29859616
Hyperkalaemia 40.83 10.06 341 90557 65669 29795911
Gangrene 38.44 10.06 58 90840 4556 29857024
Intentional product misuse 37.60 10.06 30 90868 34637 29826943
Myalgia 37.42 10.06 114 90784 76553 29785027
Drug reaction with eosinophilia and systemic symptoms 34.37 10.06 22 90876 28466 29833114
Intentional overdose 33.61 10.06 46 90852 41435 29820145
Hydrothorax 33.39 10.06 20 90878 472 29861108
Cardiac procedure complication 33.00 10.06 16 90882 243 29861337
Malnutrition 31.38 10.06 91 90807 11358 29850222
Suicidal ideation 31.37 10.06 38 90860 36076 29825504
Failure to thrive 31.33 10.06 73 90825 7981 29853599
Mental status changes 31.14 10.06 206 90692 36873 29824707
Serotonin syndrome 30.99 10.06 8 90890 17883 29843697
Completed suicide 30.49 10.06 177 90721 99315 29762265
Interstitial lung disease 30.46 10.06 88 90810 60109 29801471
Localised infection 30.08 10.06 101 90797 13636 29847944
Rash 30.07 10.06 406 90492 191483 29670097
Angioedema 30.06 10.06 36 90862 34348 29827232
Oedema 29.79 10.06 228 90670 42765 29818815
Somnolence 29.73 10.06 172 90726 96591 29764989
Staphylococcus test positive 29.52 10.06 41 90857 2986 29858594
Insomnia 29.16 10.06 165 90733 93171 29768409
Abdominal pain 28.95 10.06 575 90323 135079 29726501
Aggression 28.83 10.06 42 90856 36865 29824715
Depression 28.73 10.06 159 90739 90278 29771302
Appendicolith 28.32 10.06 23 90875 896 29860684
Drug dependence 27.73 10.06 15 90883 21280 29840300
Cardiogenic shock 27.72 10.06 113 90785 16748 29844832
Respiratory failure 27.64 10.06 444 90454 100198 29761382
Fatigue 27.30 10.06 753 90145 319920 29541660
Mycobacterial peritonitis 27.06 10.06 9 90889 46 29861534
Drug intolerance 26.93 10.06 61 90837 45230 29816350
Lower respiratory tract infection 26.68 10.06 25 90873 26689 29834891
Joint swelling 26.49 10.06 65 90833 46881 29814699
Drug resistance 26.48 10.06 14 90884 20119 29841461
Abdominal hernia 26.13 10.06 37 90861 2744 29858836
Treatment noncompliance 26.07 10.06 148 90750 25105 29836475
Diaphragmatic spasm 26.06 10.06 10 90888 82 29861498
Musculoskeletal stiffness 25.96 10.06 43 90855 35838 29825742
Gastrointestinal haemorrhage 25.94 10.06 376 90522 83070 29778510
Faecal volume decreased 25.65 10.06 10 90888 86 29861494
Blood urea increased 25.54 10.06 173 90725 31208 29830372
Intentional product use issue 25.15 10.06 45 90853 36395 29825185
Asthenia 24.96 10.06 862 90036 220428 29641152
Asthma 24.67 10.06 45 90853 36129 29825451
Administration site extravasation 24.10 10.06 15 90883 380 29861200
Multiple organ dysfunction syndrome 23.83 10.06 296 90602 63191 29798389
Hip fracture 23.66 10.06 81 90817 11043 29850537
Blood glucose decreased 23.49 10.06 90 90808 12963 29848617
Extremity necrosis 23.44 10.06 27 90871 1628 29859952
Sopor 23.13 10.06 3 90895 10988 29850592
Eosinophilia 23.01 10.06 20 90878 22140 29839440
Contraindicated product administered 22.64 10.06 12 90886 17219 29844361
Blood potassium increased 22.31 10.06 103 90795 16110 29845470
Therapeutic product effect decreased 21.83 10.06 34 90864 29042 29832538
Intentional self-injury 21.69 10.06 7 90891 13525 29848055
Foetal exposure during pregnancy 21.64 10.06 50 90848 36821 29824759
Osteonecrosis of jaw 21.62 10.06 15 90883 18603 29842977
Cerebrovascular accident 21.33 10.06 364 90534 83113 29778467
Product use issue 21.33 10.06 70 90828 45946 29815634
Cytokine release syndrome 20.84 10.06 72 90826 9861 29851719
Disturbance in attention 20.62 10.06 22 90876 22107 29839473
Product substitution issue 20.51 10.06 3 90895 10032 29851548
Product prescribing error 20.08 10.06 13 90885 16720 29844860
Withdrawal of life support 20.07 10.06 6 90892 20 29861560
Pleuroperitoneal communication 19.97 10.06 7 90891 43 29861537
Diabetic ulcer 19.88 10.06 9 90889 116 29861464
Inappropriate schedule of product administration 19.42 10.06 59 90839 39669 29821911
Right ventricular failure 19.32 10.06 61 90837 7975 29853605
Sedation 19.27 10.06 13 90885 16360 29845220
Anxiety 19.26 10.06 177 90721 89694 29771886
Psoriatic arthropathy 19.25 10.06 12 90886 15749 29845831
Swelling 19.20 10.06 180 90718 35795 29825785
Red blood cells urine positive 19.01 10.06 24 90874 1593 29859987
Dyskinesia 18.94 10.06 23 90875 21811 29839769
Peripheral vascular disorder 18.89 10.06 46 90852 5173 29856407
Therapeutic response decreased 18.73 10.06 28 90870 24321 29837259
Cardiomyopathy 18.53 10.06 93 90805 15050 29846530
Hypoglycaemia 18.40 10.06 236 90662 50745 29810835
Hypernatraemia 18.17 10.06 57 90841 7427 29854153
Pruritus 17.80 10.06 252 90646 117952 29743628
Metabolic alkalosis 17.75 10.06 21 90877 1303 29860277
Generalised tonic-clonic seizure 17.59 10.06 20 90878 19531 29842049
Diabetic vascular disorder 17.58 10.06 7 90891 64 29861516
Gait disturbance 17.47 10.06 144 90754 74633 29786947
Rhabdomyolysis 17.45 10.06 117 90781 63463 29798117
Osteonecrosis 17.44 10.06 14 90884 16121 29845459
Calciphylaxis 17.41 10.06 19 90879 1079 29860501
Bacteraemia 17.27 10.06 93 90805 15467 29846113
Hepatocellular carcinoma 17.22 10.06 4 90894 9606 29851974
Complication associated with device 17.18 10.06 47 90851 5673 29855907
Cytomegalovirus infection 16.55 10.06 29 90869 23645 29837935
Drug hypersensitivity 16.44 10.06 131 90767 68388 29793192
Oropharyngeal pain 16.43 10.06 39 90859 28457 29833123
Tachypnoea 16.34 10.06 89 90809 14863 29846717
Neutropenia 16.33 10.06 283 90615 128257 29733323
Urticaria 16.26 10.06 98 90800 54508 29807072
Spinal muscular atrophy 16.13 10.06 9 90889 185 29861395
Rash maculo-papular 16.13 10.06 33 90865 25385 29836195
Bacterial translocation 16.08 10.06 10 90888 253 29861327
Swelling of eyelid 16.04 10.06 11 90887 330 29861250
Wrong product administered 15.97 10.06 40 90858 4578 29857002
Hepatotoxicity 15.86 10.06 19 90879 18126 29843454
Hospitalisation 15.71 10.06 75 90823 44244 29817336
Cardiovascular insufficiency 15.71 10.06 21 90877 1475 29860105
Abdominal discomfort 15.61 10.06 221 90677 48570 29813010
Atrial fibrillation 15.55 10.06 434 90464 107690 29753890
Loss of personal independence in daily activities 15.40 10.06 26 90872 21509 29840071
Psychotic disorder 15.36 10.06 26 90872 21489 29840091
Therapeutic product effect prolonged 15.31 10.06 10 90888 276 29861304
Squamous cell carcinoma 15.24 10.06 6 90892 10244 29851336
Infusion site necrosis 15.18 10.06 4 90894 7 29861573
Blood albumin decreased 15.17 10.06 77 90821 12515 29849065
Hallucination 15.16 10.06 87 90811 48972 29812608
Urinary tract infection 14.95 10.06 310 90588 73349 29788231
Dyspnoea 14.92 10.06 1189 89709 332106 29529474
Pneumocystis jirovecii pneumonia 14.88 10.06 18 90880 17102 29844478
Cognitive disorder 14.83 10.06 31 90867 23659 29837921
Feeling abnormal 14.81 10.06 106 90792 56650 29804930
Postoperative wound infection 14.79 10.06 38 90860 4417 29857163
International normalised ratio increased 14.78 10.06 215 90683 47524 29814056
Epilepsy 14.75 10.06 24 90874 20145 29841435
Vertigo 14.69 10.06 29 90869 22606 29838974
Tremor 14.64 10.06 152 90746 75211 29786369
Mental impairment 14.52 10.06 5 90893 9272 29852308
Prescribed overdose 14.50 10.06 4 90894 8557 29853023
Visual acuity reduced 14.49 10.06 16 90882 15830 29845750
Polyneuropathy 14.44 10.06 9 90889 11814 29849766
Nosocomial infection 14.42 10.06 18 90880 1181 29860399
Bone marrow failure 14.41 10.06 146 90752 29639 29831941
Lymphocyte count decreased 14.30 10.06 103 90795 18952 29842628
Intercepted medication error 14.25 10.06 12 90886 492 29861088
Dizziness 14.22 10.06 467 90431 194442 29667138
Osteoarthritis 14.21 10.06 21 90877 18328 29843252
Scrotal swelling 14.13 10.06 19 90879 1342 29860238
Immune reconstitution inflammatory syndrome 14.08 10.06 5 90893 9096 29852484
Mood swings 14.02 10.06 3 90895 7623 29853957
Oedema peripheral 13.90 10.06 420 90478 105412 29756168
Pulmonary hypertension 13.77 10.06 102 90796 18934 29842646
Acute respiratory failure 13.62 10.06 129 90769 25721 29835859
Blood glucose increased 13.50 10.06 262 90636 61268 29800312
Pseudomonas test positive 13.43 10.06 16 90882 1000 29860580
Marasmus 13.30 10.06 12 90886 540 29861040
Sinusitis 13.29 10.06 54 90844 33291 29828289
Product contamination microbial 13.29 10.06 13 90885 649 29860931
Injection site bruising 13.26 10.06 3 90895 7335 29854245
Tendonitis 13.16 10.06 4 90894 8032 29853548
Withdrawal syndrome 13.15 10.06 9 90889 11241 29850339
Paraesthesia 12.97 10.06 104 90794 54223 29807357
Blood creatine phosphokinase increased 12.89 10.06 79 90819 43769 29817811
Anger 12.86 10.06 9 90889 11111 29850469
Catheter site extravasation 12.69 10.06 6 90892 86 29861494
Mania 12.59 10.06 6 90892 9148 29852432
Hyperinsulinaemia 12.56 10.06 6 90892 88 29861492
Product container issue 12.53 10.06 14 90884 816 29860764
Constipation 12.48 10.06 439 90459 112467 29749113
Dystonia 12.45 10.06 7 90891 9720 29851860
Appendicitis 12.43 10.06 44 90854 6100 29855480
Schizophrenia 12.34 10.06 6 90892 9042 29852538
Gastric ischaemia 12.33 10.06 3 90895 3 29861577
Cardiac index decreased 12.33 10.06 3 90895 3 29861577
Posthaemorrhagic hydrocephalus 12.32 10.06 6 90892 92 29861488
Mesenteric artery stenosis 12.26 10.06 4 90894 19 29861561
Sputum increased 12.26 10.06 21 90877 1836 29859744
Arthropathy 12.25 10.06 28 90870 20699 29840881
Haemoglobin decreased 12.21 10.06 442 90456 113656 29747924
Irritability 12.17 10.06 33 90865 23017 29838563
Arthritis 12.09 10.06 36 90862 24365 29837215
Erythema 12.05 10.06 164 90734 77287 29784293
Face oedema 12.05 10.06 10 90888 11324 29850256
Memory impairment 11.99 10.06 65 90833 37109 29824471
Blood pressure decreased 11.92 10.06 205 90693 46870 29814710
Pemphigoid 11.88 10.06 4 90894 7524 29854056
Application site laceration 11.78 10.06 4 90894 22 29861558
Depressed mood 11.77 10.06 21 90877 17008 29844572
Poor peripheral circulation 11.69 10.06 19 90879 1591 29859989
Shoshin beriberi 11.44 10.06 5 90893 59 29861521
Pneumoperitoneum 11.43 10.06 19 90879 1621 29859959
Leukopenia 11.43 10.06 112 90786 56047 29805533
Gamma-glutamyltransferase increased 11.40 10.06 48 90850 29302 29832278
Red blood cell sedimentation rate increased 11.30 10.06 4 90894 7291 29854289
Critical illness 11.27 10.06 6 90892 112 29861468
Respiratory tract infection bacterial 11.23 10.06 11 90887 550 29861030
Cellulitis 11.22 10.06 202 90696 46582 29814998
Injection site oedema 11.18 10.06 6 90892 114 29861466
Sensory integrative dysfunction 11.09 10.06 4 90894 27 29861553
Angina pectoris 11.03 10.06 49 90849 29469 29832111
Herpes zoster 11.01 10.06 50 90848 29893 29831687
Post procedural complication 10.99 10.06 67 90831 11659 29849921
Emotional disorder of childhood 10.97 10.06 4 90894 28 29861552
Body temperature decreased 10.92 10.06 8 90890 9647 29851933
Pathogen resistance 10.84 10.06 6 90892 8404 29853176
Drug withdrawal syndrome 10.73 10.06 28 90870 19781 29841799
Hypovolaemia 10.63 10.06 53 90845 8552 29853028
Hepatic enzyme increased 10.56 10.06 59 90839 33435 29828145
Glycosylated haemoglobin increased 10.56 10.06 8 90890 9483 29852097
Injection site erythema 10.55 10.06 16 90882 13818 29847762
Myocardial oedema 10.55 10.06 5 90893 72 29861508
Blood calcium decreased 10.51 10.06 57 90841 9505 29852075
Incorrect drug administration rate 10.50 10.06 15 90883 1121 29860459
Peripheral swelling 10.48 10.06 251 90647 60823 29800757
Incarcerated umbilical hernia 10.40 10.06 4 90894 33 29861547
Peripheral circulatory failure 10.35 10.06 7 90891 205 29861375
Salivary hypersecretion 10.34 10.06 5 90893 7561 29854019
Hepatitis C 10.34 10.06 15 90883 13190 29848390
Pericardial fibrosis 10.30 10.06 4 90894 34 29861546
Injection site swelling 10.29 10.06 7 90891 8773 29852807
Urine potassium increased 10.27 10.06 3 90895 9 29861571
Metamyelocyte percentage increased 10.27 10.06 3 90895 9 29861571
Erectile dysfunction 10.26 10.06 25 90873 18077 29843503
Pain 10.26 10.06 424 90474 172217 29689363
Peritoneal perforation 10.20 10.06 4 90894 35 29861545
Septic shock 10.20 10.06 259 90639 63348 29798232
Basal cell carcinoma 10.08 10.06 21 90877 16047 29845533
Panic attack 10.07 10.06 7 90891 8674 29852906

Pharmacologic Action:

SourceCodeDescription
ATC B05CX01 BLOOD AND BLOOD FORMING ORGANS
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
IRRIGATING SOLUTIONS
Other irrigating solutions
ATC C05BB56 CARDIOVASCULAR SYSTEM
VASOPROTECTIVES
ANTIVARICOSE THERAPY
Sclerosing agents for local injection
ATC V04CA02 VARIOUS
DIAGNOSTIC AGENTS
OTHER DIAGNOSTIC AGENTS
Tests for diabetes
ATC V06DC01 VARIOUS
GENERAL NUTRIENTS
OTHER NUTRIENTS
Carbohydrates
CHEBI has role CHEBI:75771 mus musculus metabolite
CHEBI has role CHEBI:75772 baker's yeast metabolite
CHEBI has role CHEBI:76971 e.coli metabolites
CHEBI has role CHEBI:77746 h. sapiens metabolites
MeSH PA D005421 Flavoring Agents
MeSH PA D005503 Food Additives
MeSH PA D013549 Sweetening Agents
CHEBI has role CHEBI:78675 essential metabolite

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Hypoglycemia indication 302866003 DOID:9993

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 11.87 acidic
pKa2 13.08 acidic
pKa3 13.91 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
5SL0G7R0OK UNII
4019541 VUID
N0000147647 NUI
D00009 KEGG_DRUG
50-99-7 SECONDARY_CAS_RN
4017760 VANDF
4019541 VANDF
C1165353 UMLSCUI
CHEBI:17634 CHEBI
GLO PDB_CHEM_ID
5793 PUBCHEM_CID
CHEMBL1222250 ChEMBL_ID
CHEMBL1614854 ChEMBL_ID
DB01914 DRUGBANK_ID
DB09341 DRUGBANK_ID
D005947 MESH_DESCRIPTOR_UI
4536 IUPHAR_LIGAND_ID
1299920 RXNORM
11133 MMSL
4567 MMSL
4787 MMSL
71873 MMSL
71874 MMSL
9763 MMSL
d00595 MMSL
000915 NDDF
002597 NDDF
111138002 SNOMEDCT_US
67079006 SNOMEDCT_US
725859007 SNOMEDCT_US
768547002 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Dextrose HUMAN PRESCRIPTION DRUG LABEL 1 0264-1290 INJECTION, SOLUTION 70 g INTRAVENOUS UNULLPPROVED DRUG OTHER 24 sections
Dextrose HUMAN PRESCRIPTION DRUG LABEL 1 0264-1510 INJECTION, SOLUTION 50 mg INTRAVENOUS NDA 24 sections
MYOCARD-DX HUMAN PRESCRIPTION DRUG LABEL 2 0264-1840 INJECTION 5 g INTRAVENOUS EXPORT ONLY 20 sections
MYOCARD-DX HUMAN PRESCRIPTION DRUG LABEL 2 0264-1880 INJECTION 5 g INTRAVENOUS EXPORT ONLY 20 sections
Isolyte P in Dextrose HUMAN PRESCRIPTION DRUG LABEL 5 0264-7730 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 23 sections
Dextrose in Lactated Ringers HUMAN PRESCRIPTION DRUG LABEL 5 0264-7751 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 23 sections
Theophylline in Dextrose HUMAN PRESCRIPTION DRUG LABEL 2 0264-9554 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 27 sections
Heparin Sodium in Dextrose HUMAN PRESCRIPTION DRUG LABEL 2 0264-9567 INJECTION 5 g INTRAVENOUS NDA 19 sections
Heparin Sodium in Dextrose HUMAN PRESCRIPTION DRUG LABEL 2 0264-9577 INJECTION 5 g INTRAVENOUS NDA 19 sections
Heparin Sodium in Dextrose HUMAN PRESCRIPTION DRUG LABEL 2 0264-9587 INJECTION 5 g INTRAVENOUS NDA 19 sections
Lidocaine Hydrochloride and Dextrose HUMAN PRESCRIPTION DRUG LABEL 2 0264-9594 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 23 sections
Lidocaine Hydrochloride and Dextrose HUMAN PRESCRIPTION DRUG LABEL 2 0264-9598 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 23 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0017 INJECTION, SOLUTION 50 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0023 INJECTION, SOLUTION 100 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0062 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0066 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0070 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 2 0338-0073 INJECTION, SOLUTION 2.50 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0074 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 2 0338-0077 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0078 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 2 0338-0081 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
DEXTROSE HUMAN PRESCRIPTION DRUG LABEL 1 0338-0082 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 2 0338-0085 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 2 0338-0089 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Lactated Ringers and Dextrose HUMAN PRESCRIPTION DRUG LABEL 5 0338-0125 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 18 sections
Dextrose and Electrolyte No. 48 HUMAN PRESCRIPTION DRUG LABEL 6 0338-0143 INJECTION 5 g INTRAVENOUS NDA 19 sections
Dextrose HUMAN PRESCRIPTION DRUG LABEL 1 0338-0551 INJECTION 5 g INTRAVENOUS NDA 21 sections
Potassium Chloride in Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 3 0338-0603 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections
Potassium Chloride in Dextrose and Sodium Chloride HUMAN PRESCRIPTION DRUG LABEL 3 0338-0663 INJECTION, SOLUTION 5 g INTRAVENOUS NDA 21 sections